Fennec Pharmaceuticals Announces FDA Acceptance for Filing of New Drug Application Resubmission for PEDMARK™GlobeNewsWire • 04/27/22
FENC Final Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Fennec Pharmaceuticals Inc. Investors of Class Action and Last Few Hours to Contact the FirmBusiness Wire • 04/11/22
FENC FINAL DEADLINE TODAY: ROSEN, A LEADING LAW FIRM, Encourages Fennec Pharmaceuticals Inc. Investors with Losses to Secure Counsel Before Important April 11 Deadline in Securities Class Action - FENCNewsfile Corp • 04/11/22
CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Fennec Investors of a Lead Plaintiff Deadline of April 11, 2022PRNewsWire • 04/11/22
FENC FINAL DEADLINE TOMORROW: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Fennec Pharmaceuticals Inc. Investors with Losses to Secure Counsel Before Important April 11 Deadline in Securities Class Action - FENCNewsfile Corp • 04/10/22
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Fennec Pharmaceuticals Inc. of Class Action Lawsuit and Upcoming Deadline - FENCNewsfile Corp • 04/09/22
FENC FINAL DEADLINE MONDAY: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Fennec Pharmaceuticals Inc. Investors with Losses to Secure Counsel Before Important April 11 Deadline in Securities Class Action - FENCNewsfile Corp • 04/08/22
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Fennec Pharmaceuticals Inc. (FENC)Business Wire • 04/08/22
FENC SHAREHOLDER ALERT: Jakubowitz Law Reminds Fennec Shareholders of a Lead Plaintiff Deadline of April 11, 2022PRNewsWire • 04/08/22
FENC LAWSUIT ALERT: Levi & Korsinsky Notifies Fennec Pharmaceuticals Inc. Investors of a Class Action Lawsuit and Upcoming DeadlinePRNewsWire • 04/07/22
FENC MONDAY DEADLINE: ROSEN, A TOP RANKED FIRM, Encourages Fennec Pharmaceuticals Inc. Investors With Losses Over $100K to Secure Counsel Before Important April 11 Deadline in Securities Class Action - FENCNewsfile Corp • 04/06/22
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Fennec Pharmaceuticals Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of April 11, 2022 - (NASDAQ: FENC)PRNewsWire • 04/06/22
FENC ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of April 11, 2022 in the Class Action Filed on Behalf of Fennec Pharmaceuticals Inc. ShareholdersPRNewsWire • 04/05/22
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Fennec Pharmaceuticals Inc. Investors to Secure Counsel Before Important April 11 Deadline in Securities Class Action - FENCNewsfile Corp • 04/03/22
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Fennec Pharmaceuticals Inc. Investors With Losses to Secure Counsel Before Important April 11 Deadline in Securities Class Action - FENCNewsfile Corp • 04/01/22
Fennec Class Action: Levi & Korsinsky Reminds Fennec Pharmaceuticals Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 11, 2022 - FENCNewsfile Corp • 03/31/22
ROSEN, A TOP RANKED FIRM, Encourages Fennec Pharmaceuticals Inc. Investors to Secure Counsel Before Important April 11 Deadline in Securities Class Action - FENCNewsfile Corp • 03/31/22
FENC FINAL DEADLINE: ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Fennec Pharmaceuticals Inc. Investors With Losses Exceeding $100K to Secure Counsel Before Important April 11 Deadline in Securities Class Action - FENCNewsfile Corp • 03/30/22
ROSEN, A LEADING LAW FIRM, Encourages Fennec Pharmaceuticals Inc. Investors With Losses Over $100K to Secure Counsel Before Important April 11 Deadline in Securities Class Action - FENCPRNewsWire • 03/29/22
ROSEN, A LEADING LAW FIRM, Encourages Fennec Pharmaceuticals Inc. Investors With Losses to Secure Counsel Before Important April 11 Deadline in Securities Class Action - FENCNewsfile Corp • 03/27/22
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Fennec Pharmaceuticals Inc. Investors to Secure Counsel Before Important April 11 Deadline in Securities Class Action - FENCNewsfile Corp • 03/26/22
ROSEN, A TOP RANKED FIRM, Encourages Fennec Pharmaceuticals Inc. Investors With Losses Over $100K to Secure Counsel Before Important April 11 Deadline in Securities Class Action - FENCNewsfile Corp • 03/25/22
Fennec Pharmaceuticals to Participate in the 2022 Maxim Virtual Growth ConferenceGlobeNewsWire • 03/25/22
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Fennec Pharmaceuticals Inc. Investors With Losses Exceeding $100K to Secure Counsel Before Important April 11 Deadline in Securities Class Action - FENCNewsfile Corp • 03/24/22
Fennec Pharmaceuticals Resubmits New Drug Application to U.S. Food and Drug Administration for Pedmark™GlobeNewsWire • 03/24/22
